View Section: Financials
Jiangsu Recbio Statements
21
Jiangsu Recbio Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2023-06-30
%
—
—
—
247.82
83.526
326.87
-326.87
49.67
—
-276.94
—
-272.55
-0.565
482.13
2022-12-31
%
—
100
—
0
—
0
361.98
0
83.509
0
442.12
0
-442.12
0
63.296
0
—
0
-378.88
0
—
0
-373.02
0
-0.772
483.11
2022-06-30
%
—
100
—
0
—
0
354.47
0
80.447
0
432.88
0
-432.88
0
75.764
0
—
0
-357.12
0
—
0
-349.69
0
-0.751
465.32
2021-12-31
%
—
100
—
0
—
0
101.17
0
28.355
0
127.8
0
-127.8
0
-9.398
0
—
0
-137.2
0
—
0
-137.2
0
-0.286
479.1
2021-09-30
%
—
100
—
0
—
0
371.78
0
118.15
0
486.52
0
-486.52
0
-33.829
0
—
0
-520.36
0
—
0
-520.36
0
-1.086
479.1
2020-12-31
%
—
100
—
0
—
0
78.357
0
7.803
0
84.808
0
-84.808
0
-22.08
0
—
0
-106.91
0
—
0
-106.91
0
-0.223
479.1
2020-09-30
%
—
100
—
0
—
0
52.162
0
10.613
0
62.606
0
-62.606
0
-9.882
0
—
0
-72.494
0
—
0
-72.494
0
-0.151
479.1
View Section: Balance Sheet